Breast cancer and hormone-replacement therapy: up to general practice to pick up the pieces
- 1 August 2003
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 362 (9382), 414-415
- https://doi.org/10.1016/s0140-6736(03)14095-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal WomenJAMA, 2003
- Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast CancerJAMA, 2003
- Is primary-care research a lost cause?The Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable HistologyJAMA, 1999
- Evidence-based interventions and comprehensive treatmentThe Lancet, 1999
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Postmenopausal Hormone Therapy and MortalityNew England Journal of Medicine, 1997